↓ Skip to main content

A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, December 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#24 of 3,289)
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news
2 news outlets
blogs
1 blog
twitter
13 X users
patent
17 patents
wikipedia
2 Wikipedia pages
reddit
1 Redditor

Readers on

mendeley
309 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors
Published in
Cancer Chemotherapy and Pharmacology, December 2012
DOI 10.1007/s00280-012-2045-1
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 13 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 309 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
United States 1 <1%
Portugal 1 <1%
United Kingdom 1 <1%
Czechia 1 <1%
Unknown 305 99%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Ph. D. Student 59 19%
Researcher 43 14%
Student > Master 40 13%
Student > Bachelor 29 9%
Student > Doctoral Student 17 6%
Other 41 13%
Unknown 80 26%
Readers by discipline
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 62 20%
Agricultural and Biological Sciences 41 13%
Medicine and Dentistry 32 10%
Pharmacology, Toxicology and Pharmaceutical Science 21 7%
Chemistry 18 6%
Other 42 14%
Unknown 93 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 43. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 May 2026.
All research outputs
#1,170,942
of 32,463,143 outputs
Outputs from Cancer Chemotherapy and Pharmacology
#24
of 3,289 outputs
Outputs of similar age
#8,014
of 333,468 outputs
Outputs of similar age from Cancer Chemotherapy and Pharmacology
#2
of 28 outputs
Altmetric has tracked 32,463,143 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,289 research outputs from this source. They receive a mean Attention Score of 4.7. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 333,468 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.